Intervention: Standard dose cytarabine for induction
Found 110 matching trials
Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old
PHASE1
A phase I-II trial based on the combination of three drugs regimen LDAC or ...
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
PHASE1
Ziftomenib is an investigational drug in development for the treatment of p...
A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients †60 Years Old
PHASE3
The study will include newly-diagnosed AML patients, not suffering acute pr...